Key facts
- This page summarizes Michael E. Tarvin's Form 4 filing for SELECT MEDICAL HOLDINGS CORP (SEM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Aug 2025, 16:18.
Michael E. Tarvin - 01 Aug 2025 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)
- Reporting relationship
- EXECUTIVE VICE PRESIDENT
- Issuer ticker
- SEM
- Reported as of
- 01 Aug 2025
- Net transaction value
- -$246,875
- SEC form
- 4
- Accepted by SEC
- 04 Aug 2025, 16:18:15 UTC
- Prior SEC filing
- 31 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael E. Tarvin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael E. Tarvin filed Form 4 for SELECT MEDICAL HOLDINGS CORP (SEM) on 04 Aug 2025.
Change
- Previous filing in this sequence was filed on 31 Jul 2025.
- Current net transaction value: -$246,875.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001168884
Primary reporting owner
TARVIN MICHAEL E
- Relationship
- EXECUTIVE VICE PRESIDENT
- Address
- C/O SELECT MEDICAL HOLDINGS CORPORATION, 4714 GETTYSBURG ROAD, MECHANICSBURG
- Signature
- /s/ Michael E. Tarvin, Attorney-in-Fact
- Signature date
- 04 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SEM
transaction
Common Stock
Tax liability
- Transaction value
- $246,875
- Shares
- -19,640
- Change %
- -3.7%
- Price
- $12.57
- Shares after
- 508,120
- Date
- 01 Aug 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock.